• Profile
Close

Effectiveness of single-dose azithromycin to treat latent yaws: A longitudinal comparative cohort study

The Lancet Global Health Nov 16, 2017

Mitja O, et al. - The goal of this paper was to analyze the effectiveness of single-dose azithromycin to treat patients with latent yaws. Oral single-dose azithromycin was discovered to be effective in individuals with latent yaws, on the basis of the decline in serological titre. The yielded data supported the WHO strategy for the eradication of yaws based on the mass administration of the entire endemic community, regardless of the clinical status.
Full text available Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay